Taiko Pharmaceutical Co.,Ltd. (4574.T)

JPY 322.0

(0.0%)

Long Term Debt Summary of Taiko Pharmaceutical Co.,Ltd.

  • Taiko Pharmaceutical Co.,Ltd.'s latest annual long term debt in 2022 was 2.74 Billion JPY , down -28.13% from previous year.
  • Taiko Pharmaceutical Co.,Ltd.'s latest quarterly long term debt in 2023 Q3 was 1.87 Billion JPY , down -15.0% from previous quarter.
  • Taiko Pharmaceutical Co.,Ltd. reported annual long term debt of 3.81 Billion JPY in 2021, up 5876.84% from previous year.
  • Taiko Pharmaceutical Co.,Ltd. reported annual long term debt of 63.81 Million JPY in 2020, up 22.14% from previous year.
  • Taiko Pharmaceutical Co.,Ltd. reported quarterly long term debt of 2.46 Billion JPY for 2023 Q1, down -10.25% from previous quarter.
  • Taiko Pharmaceutical Co.,Ltd. reported quarterly long term debt of 1.87 Billion JPY for 2023 Q3, down -15.0% from previous quarter.

Annual Long Term Debt Chart of Taiko Pharmaceutical Co.,Ltd. (2022 - 2007)

Historical Annual Long Term Debt of Taiko Pharmaceutical Co.,Ltd. (2022 - 2007)

Year Long Term Debt Long Term Debt Growth
2022 2.74 Billion JPY -28.13%
2021 3.81 Billion JPY 5876.84%
2020 63.81 Million JPY 22.14%
2019 52.24 Million JPY 33.28%
2018 39.2 Million JPY 155.3%
2017 15.35 Million JPY -17.89%
2016 18.7 Million JPY -32.86%
2015 27.85 Million JPY -23.3%
2014 36.31 Million JPY 31.37%
2013 27.64 Million JPY 130.18%
2012 12 Million JPY -45.12%
2011 21.88 Million JPY -41.17%
2010 37.19 Million JPY -21.03%
2009 47.1 Million JPY 55.0%
2008 30.38 Million JPY 0.0%
2007 - JPY 0.0%

Peer Long Term Debt Comparison of Taiko Pharmaceutical Co.,Ltd.

Name Long Term Debt Long Term Debt Difference
Pharma Foods International Co., Ltd. 1.23 Billion JPY -122.665%
Takeda Pharmaceutical Company Limited 4476.5 Billion JPY 99.939%
Sumitomo Pharma Co., Ltd. 133.36 Billion JPY 97.945%
Shionogi & Co., Ltd. 8.75 Billion JPY 68.685%
Wakamoto Pharmaceutical Co.,Ltd. - JPY -Infinity%
Nippon Shinyaku Co., Ltd. 1.15 Billion JPY -137.934%
Kaken Pharmaceutical Co., Ltd. - JPY -Infinity%
Eisai Co., Ltd. 134.77 Billion JPY 97.966%
Morishita Jintan Co., Ltd. 106 Million JPY -2485.849%
Hisamitsu Pharmaceutical Co., Inc. 76 Million JPY -3506.579%
Mochida Pharmaceutical Co., Ltd. - JPY -Infinity%
Fuso Pharmaceutical Industries,Ltd. 7.02 Billion JPY 60.96%
Nippon Chemiphar Co., Ltd. 13.34 Billion JPY 79.459%
Tsumura & Co. 54.37 Billion JPY 94.959%
Kissei Pharmaceutical Co., Ltd. - JPY -Infinity%
Torii Pharmaceutical Co., Ltd. 22 Million JPY -12359.091%
Towa Pharmaceutical Co., Ltd. 189.12 Billion JPY 98.551%
Fuji Pharma Co., Ltd. 11.92 Billion JPY 77.013%
Zeria Pharmaceutical Co., Ltd. 7.94 Billion JPY 65.495%
KYORIN Holdings, Inc. 435 Million JPY -530.115%
Daito Pharmaceutical Co.,Ltd. 4.66 Billion JPY 41.294%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 27 Million JPY -10051.852%
Modalis Therapeutics Corporation 412.5 Million JPY -564.485%
ASKA Pharmaceutical Holdings Co.,Ltd. 4.5 Billion JPY 39.156%
Sawai Group Holdings Co., Ltd. 66.84 Billion JPY 95.899%
Cyfuse Biomedical K.K. 345 Million JPY -694.493%
Toho Holdings Co., Ltd. 28.16 Billion JPY 90.268%
Koa Shoji Holdings Co.,Ltd. 1.59 Billion JPY -72.24%